Donna Cochener - Mar 14, 2022 Form 3 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Signature
/s/ Sean Smith, as Attorney-in-Fact for Donna Cochener
Stock symbol
NLTX
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
3
Date filed
3/15/2022, 06:03 PM
Next filing
Aug 4, 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24 - Power of Attorney